KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.84% | -4.22% | -7.65% | -12.27% | -10.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.88% | 3.29% | -1.71% | -3.80% | 3.27% |
| Operating Income | -4.88% | -3.29% | 1.71% | 3.80% | -3.27% |
| Income Before Tax | 29.94% | 8.01% | 3.85% | 9.86% | 8.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.94% | 8.01% | 3.85% | 9.86% | 8.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.94% | 8.01% | 3.85% | 9.86% | 8.74% |
| EBIT | -4.88% | -3.29% | 1.71% | 3.80% | -3.27% |
| EBITDA | -4.77% | -3.13% | 1.70% | 3.75% | -3.41% |
| EPS Basic | 62.46% | 52.39% | 51.27% | 45.57% | 38.50% |
| Normalized Basic EPS | 51.51% | 41.74% | 49.52% | 42.81% | 33.30% |
| EPS Diluted | 62.46% | 52.39% | 51.27% | 45.57% | 38.51% |
| Normalized Diluted EPS | 51.51% | 41.74% | 49.52% | 42.81% | 33.30% |
| Average Basic Shares Outstanding | 114.86% | 86.47% | 99.72% | 78.70% | 56.03% |
| Average Diluted Shares Outstanding | 114.86% | 86.47% | 99.72% | 78.70% | 56.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |